Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2015 | 06-2014 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 7 | 4 |
| Accounts receivable | 15 | -53 |
| Other Working Capital | 222 | -52 |
| Other Operating Activity | -1,738 | -668 |
| Operating Cash Flow | $-1,493 | $-768 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 0 | -12 |
| Purchase Sale Intangibles | -38 | -20 |
| Investing Cash Flow | $-38 | $-32 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 3,131 | 1,114 |
| Other Financing Activity | -296 | 170 |
| Financing Cash Flow | $2,834 | $1,283 |
| Beginning Cash Position | 1,189 | 706 |
| End Cash Position | 2,492 | 1,189 |
| Net Cash Flow | $1,303 | $483 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,493 | -768 |
| Capital Expenditure | -38 | -32 |
| Free Cash Flow | -1,531 | -800 |